Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omega Healthcare InvestorsBSP:O2HI34 46 Price-to-Tangible-Book is 1.01 as of Aug. 09, 2026, which is 59% below its 10-year median of 2.48. GuruFocus rates BSP:O2HI34 with a GF Score™ of 46/100 and a GF Value™ of R$70.35 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 912 REITs companies, Omega Healthcare Investors ranks worse than 95.29% on this metric.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Omega Healthcare Investors Price-to-Tangible-Book Related Terms
Omega Healthcare Investors Price-to-Tangible-Book Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: Price-to-Tangible-Book Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Price-to-Tangible-Book vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Omega Healthcare Investors (BSP:O2HI34) has a Price-to-Tangible-Book of 1.01 as of Aug. 09, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Omega Healthcare Investors and its competitors. This is 59% below median its historical median of 2.48. Over the past decade, Omega Healthcare Investors' Price-to-Tangible-Book has ranged from 1.78 to 3.06. According to the industry distribution chart, Omega Healthcare Investors ranks #869 out of 912 companies in the REITs industry, placing it in the top 95.3%.
Is Omega Healthcare Investors' Price-to-Tangible-Book too high?
Omega Healthcare Investors' current Price-to-Tangible-Book of 1.01 is 59% below median its 10-year median of 2.48. Over the past 10 years, this metric has ranged from a low of 1.78 to a high of 3.06. The REITs industry median Price-to-Tangible-Book is 0.86. Omega Healthcare Investors' value of 1.01 is 17.4% above this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #869 out of 912 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Price-to-Tangible-Book compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #869 out of 912 companies for Price-to-Tangible-Book. This places Omega Healthcare Investors in the lower half of its industry. The industry median Price-to-Tangible-Book is 0.86. Omega Healthcare Investors' value of 1.01 is 17.4% above this benchmark. Historically, Omega Healthcare Investors' own Price-to-Tangible-Book has ranged from 1.78 to 3.06 over the past decade. While the company's 10-year median is 2.48 vs. the industry median of 0.86, Omega Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a REITs company?
The median Price-to-Tangible-Book among REITs companies is 0.86, based on 912 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Price-to-Tangible-Book of 1.01 is 17.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median Price-to-Tangible-Book is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Price-to-Tangible-Book is 1.01, which is 59% below median its own 10-year median of 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$70.35, compared to a current price of R$81.84 — trading 16.3% above its estimated fair value. The current Price-to-Tangible-Book is 1.01, which is 59% below median its 10-year median of 2.48 and 17.4% above the REITs industry median of 0.86. Omega Healthcare Investors' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Price-to-Tangible-Book is 1.01 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$81.84 is trading 16.3% above its estimated GF Value™ of R$70.35.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Price-to-Tangible-Book: 1.01 (59% below median its 10-year median of 2.48)
GF Value™: R$70.35 vs. price of R$81.84 (16.3% above fair value)
Industry Position: 17.4% above the REITs median (#869 of 912)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
46GF Score
Get the complete analysis for BSP:O2HI34
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
